Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19-Reply

被引：0
|
作者：
Vandebosch, An [1 ]
Sadoff, Jerald [2 ]
Douoguih, Macaya [2 ]
机构：
[1] Janssen Res & Dev, Beerse, Belgium
[2] Janssen Vaccines & Prevent, Leiden, Netherlands
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2021年
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination
    Marcel Kemper
    Christoph Berssenbrügge
    Georg Lenz
    Rolf Michael Mesters
    Annals of Hematology, 2022, 101 : 927 - 928
  • [42] Vaccine-induced pseudothrombocytopenia after Ad26.COV2.S vaccination
    Kemper, Marcel
    Berssenbruegge, Christoph
    Lenz, Georg
    Mesters, Rolf Michael
    ANNALS OF HEMATOLOGY, 2022, 101 (04) : 927 - 928
  • [43] Thromboembolic Events in the South African Ad26.COV2.S Vaccine Study
    Takuva, Simbarashe
    Takalani, Azwidhwi
    Garrett, Nigel
    Goga, Ameena
    Peter, Jonny
    Louw, Vernon
    Opie, Jessica
    Jacobson, Barry
    Sanne, Ian
    Gail-Bekker, Linda
    Gray, Glenda
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (06): : 570 - 571
  • [44] Low-dose Ad26.COV2.S protection against SARS-CoV-2 challenge in rhesus macaques
    He, Xuan
    Chandrashekar, Abishek
    Zahn, Roland
    Wegmann, Frank
    Yu, Jingyou
    Mercado, Noe B.
    McMahan, Katherine
    Martinot, Amanda J.
    Piedra-Mora, Cesar
    Beecy, Sidney
    Ducat, Sarah
    Chamanza, Ronnie
    Huber, Sietske Rosendahl
    van Heerden, Marjolein
    van der Fits, Leslie
    Borducchi, Erica N.
    Lifton, Michelle
    Liu, Jinyan
    Nampanya, Felix
    Patel, Shivani
    Peter, Lauren
    Tostanoski, Lisa H.
    Pessaint, Laurent
    Van Ry, Alex
    Finneyfrock, Brad
    Velasco, Jason
    Teow, Elyse
    Brown, Renita
    Cook, Anthony
    Andersen, Hanne
    Lewis, Mark G.
    Schuitemaker, Hanneke
    Barouch, Dan H.
    CELL, 2021, 184 (13) : 3467 - +
  • [45] B cell somatic hypermutation following COVID-19 vaccination with Ad26.COV2.S
    Jacob-Dolan, Catherine
    Lifton, Michelle
    Powers, Olivia C.
    Miller, Jessica
    Hachmann, Nicole P.
    Vu, Mya
    Surve, Nehalee
    Mazurek, Camille R.
    Fisher, Jana L.
    Rodrigues, Stefanie
    Patio, Robert C.
    Anand, Trisha
    Le Gars, Mathieu
    Sadoff, Jerald
    Schmidt, Aaron G.
    Barouch, Dan H.
    ISCIENCE, 2024, 27 (05)
  • [46] Cutaneous leukocytoclastic vasculitis following COVID-19 vaccination with Ad26.COV2.S vaccine: a case report and literature review
    Betetto, Laura Dordevic
    Luzar, Bostjan
    Tkalec, Ziva Pipan
    Ponorac, Svjetlana
    ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, 2022, 31 (02): : 83 - 87
  • [47] Lymphohistocytic myocarditis after Ad26.COV2.S viral vector COVID-19 vaccination
    Ujueta, Francisco
    Azimi, Roshanak
    Lozier, Matthew R.
    Poppiti, Robert
    Ciment, Ari
    IJC HEART & VASCULATURE, 2021, 36
  • [48] Ad26.COV2-S/COVID-19-Vaccine-Pfizer-BioNTechLack of efficacy: case report
    Reactions Weekly, 2021, 1866 (1) : 15 - 15
  • [49] Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial
    Takuva, Simbarashe
    Takalani, Azwidhwi
    Seocharan, Ishen
    Yende-Zuma, Nonhlanhla
    Reddy, Tarylee
    Engelbrecht, Imke
    Faesen, Mark
    Khuto, Kentse
    Whyte, Carmen
    Bailey, Veronique
    Trivella, Valentina
    Peter, Jonathan
    Opie, Jessica E.
    Louw, Vernon
    Rowji, Pradeep
    Jacobson, Barry
    Groenewald, Pamela
    Dorrington, Rob
    Laubscher, Ria
    Bradshaw, Debbie
    Moultrie, Harry
    Fairall, Lara
    Sanne, Ian
    Gail-Bekker, Linda
    Gray, Glenda
    Goga, Ameena
    Garrett, Nigel
    Sisonke Study Team
    PLOS MEDICINE, 2022, 19 (06)
  • [50] Ad26.COV2.S: safety and efficiency data
    Vaillant-Roussel, Helene
    Cadwallader, Jean-Sebastien
    Ruelle, Yannick
    EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE, 2021, (175): : 336 - 336
12345